sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Protein Labeling Market by Labeling Method (In Vitro, In Vivo and Bioorthogonal Labeling), Application (Mass Spectrometry, Immunological Techniques, and Protein Microarray), Product Type (Kits, Reagents and Services), and End Users (Research Laboratories, Hospitals and Diagnostic Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Protein Labeling Market by Labeling Method (In Vitro, In Vivo...

Home / Categories / Healthcare
Protein Labeling Market by Labeling Method (In Vitro, In Vivo and Bioorthogonal Labeling), Application (Mass Spectrometry, Immunological Techniques, and Protein Microarray), Product Type (Kits, Reagents and Services), and End Users (Research Laboratories, Hospitals and Diagnostic Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Protein Labeling Market by Labeling...
Report Code
RO1/113/1092

Publish Date
01/Dec/2016

Pages
160
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Protein labeling is a process in biological research that uses molecular labels to create covalent bonds with the protein of interest. This helps in the detection and purification of the labeled protein and/or its binding associates. The process is carried out with the use of different labels such as, biotin, reporter enzymes, monoclonal antibodies, fluorophores, radioactive isotopes, and other tags. Specific labels are used to target a particular protein or nucleotide sequence and the labeling strategy is carefully selected and completed for each application. This process is helpful to identify proteins in tissues, cells, samples, and biochemical assays. The increase in healthcare and R&D expenditure and progress in proteomics research primarily drive the protein labeling market.

This market is estimated to reach $5,350 million by 2022 from $2,002 million in 2015, growing at a significant CAGR of 14.9% during the forecast period. Moreover, government investments on healthcare and R&D on the increase in the use of proteomics, and other applications such as diagnostics and therapeutics are expected to drive the market. However, lack of skilled professionals and accelerated market consolidation is expected to restrict the market growth.

The growth in competition has led to collaborations and product launch by major players in the protein labeling market. For instance, in September 2016, Kaneka Corporation's subsidiary, Eurogentec S.A. signed an agreement with Koram Biotech Corp. (KBC), one of the largest life science reagent and services companies in South Korea, to be the new distributor for its products. This collaboration has helped Kaneka to make a smooth entry in the South Korean market. Likewise, in June 2016, F. Hoffmann-LA Roche AG (Roche) launched a new product, Cobas E 801 module, a high-volume testing immunoassay solution that had high flexibility and continuous operation, which saves time and reduces the amount of waste generated during the process.

KEY BENEFITS

The global protein labeling market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.
The market scenario is comprehensively analyzed with respect to the application, product type, labeling method, and end users.
Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
In-depth analysis, based on geography provides an understanding of the regional market, which assists in strategic business planning.

KEY MARKET SEGMENTS

By Labeling Method

In Vitro Labeling
Nanoparticle Labeling
Site-Specific Labeling
Dye-Based Labeling
Co-Translational Labeling
Enzymatic Labeling
In Vivo Labeling
Radioactive Labeling
Photoreactive Labeling
Bioorthogonal Labeling

By Application

Cell-Based Assays
Fluorescence Microscopy
Mass Spectrometry
Immunological Techniques
Protein Microarray

By Product Type

Kits
Reagents
Enzymes
Monoclonal Antibodies
Probes/Tags
Protein
Other Reagents
Services

By End Users

Research Laboratories
Hospitals and Diagnostic Centers
Others

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Republic of South Africa
Rest of LAMEA

The key players profiled in this report include:

General Electric Company
Kaneka Corporation
LI-COR, Inc.
Merck & Co., Inc.
New England Biolabs, Inc.
PerkinElmer, Inc.
Promega Corporation
F. Hoffmann-LA Roche AG
Seracare Life Sciences, Inc.
Thermo Fisher Scientific, Inc.

The other players of the protein labeling market include (companies not profiled in the report):

Qiagen N.V.
Active Motif, Inc.
Takara Bio USA, Inc.
Candor Bioscience GMBHa
Innova Biosciences Ltd.
Luminex Corporation
Bio-Rad Laboratories
Agilent Technologies, Inc.
Caprion Biosciences
Nanotemper Technologies GMBH
Biotium, Inc.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com